1% non-fat dry milk blocking buffer (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
90
Structured Review
Cell Signaling Technology Inc
1% non-fat dry milk blocking buffer
1% Non Fat Dry Milk Blocking Buffer, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+fat+milk+blocking+buffer/1++non+fat+dry+milk+blocking+buffer/pm38802425-341-17-41
Average 90 stars, based on 1 article reviews
1% Non Fat Dry Milk Blocking Buffer, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+fat+milk+blocking+buffer/1++non+fat+dry+milk+blocking+buffer/pm38802425-341-17-41
Average 90 stars, based on 1 article reviews
1% non-fat dry milk blocking buffer - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Blocking Assay:Article Title: A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms. Article Snippet: The membranes were then blocked with 1% Article Title: Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways Article Snippet: Membranes were blocked with 5% non-fat dry milk solution (catalog number 9999) (Cell Signaling Technology, Danvers, MA) at room temperature for 1 h and reacted with the corresponding protein antibodies at 4°C overnight: myeloid differentiation primary response gene 88 (MyD88) (HFL-296, polyclonal; catalog number sc-11356), nuclear factor kappa B (NF-κB) p50 (H-119, polyclonal; catalog number sc-7178), NFκB p65 (F-6, monoclonal; catalog number sc-8008), Caspase-1 (14F468, monoclonal; catalog number sc-56036), GAPDH (FL-335, polyclonal; catalog number sc-25778) (Santa Cruz, Dallas, TX). Article Title: Knockdown of DLGAP5 suppresses cell proliferation, induces G 2 /M phase arrest and apoptosis in ovarian cancer Article Snippet: After conventional blocking with 5% skimmed non-fat dry milk (Cell Signaling Technology, Inc.) for 2 h at room temperature, the membranes were incubated overnight at 4 ̊ C with primary antibodies against CDK1 (1:1,000; cat. no. ab131450; Abcam), Cyclin B1 (1:1,000; cat. no. 4138; Cell Signaling Technology, Inc.), Bax (1:1,000; cat. no. 2772; Cell Signaling Technology, Inc.), Bcl-2 (1:1,000; cat no. sc-7382; Santa Cruz Biotechnology Inc.) and GAPDH (1:1,000; cat. no. G9545; Sigma-Aldrich; Merck KGaA) at 4 ̊C, followed by incubation with secondary antibody conjugated to horseradish peroxidase (1:5,000; cat. no. sc-2357; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. Article Title: dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation. Article Snippet: Epigenetic editing is thriving as a robust tool for manipulating transcriptional regulation and cell fate.. Despite its regulatory role in gene downregulation, epigenetic editing with histone deacetylation has been sparsely studied, especially in the context of cancer.. In this current study, we have reconstructed a dCas9-HDAC8-EGFP fusion to perform histone deacetylation on the promoter of the ESR1, TERT and CDKN1C genes for the first time in breast cancer cell lines MCF-7 and MDA-MB-231 as well as in HEK293T cells. Control:Article Title: A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms. Article Snippet: The membranes were then blocked with 1% Article Title: Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways Article Snippet: Membranes were blocked with 5% non-fat dry milk solution (catalog number 9999) (Cell Signaling Technology, Danvers, MA) at room temperature for 1 h and reacted with the corresponding protein antibodies at 4°C overnight: myeloid differentiation primary response gene 88 (MyD88) (HFL-296, polyclonal; catalog number sc-11356), nuclear factor kappa B (NF-κB) p50 (H-119, polyclonal; catalog number sc-7178), NFκB p65 (F-6, monoclonal; catalog number sc-8008), Caspase-1 (14F468, monoclonal; catalog number sc-56036), GAPDH (FL-335, polyclonal; catalog number sc-25778) (Santa Cruz, Dallas, TX). Article Title: Knockdown of DLGAP5 suppresses cell proliferation, induces G 2 /M phase arrest and apoptosis in ovarian cancer Article Snippet: After conventional blocking with 5% skimmed non-fat dry milk (Cell Signaling Technology, Inc.) for 2 h at room temperature, the membranes were incubated overnight at 4 ̊ C with primary antibodies against CDK1 (1:1,000; cat. no. ab131450; Abcam), Cyclin B1 (1:1,000; cat. no. 4138; Cell Signaling Technology, Inc.), Bax (1:1,000; cat. no. 2772; Cell Signaling Technology, Inc.), Bcl-2 (1:1,000; cat no. sc-7382; Santa Cruz Biotechnology Inc.) and GAPDH (1:1,000; cat. no. G9545; Sigma-Aldrich; Merck KGaA) at 4 ̊C, followed by incubation with secondary antibody conjugated to horseradish peroxidase (1:5,000; cat. no. sc-2357; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. Article Title: dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation. Article Snippet: Epigenetic editing is thriving as a robust tool for manipulating transcriptional regulation and cell fate.. Despite its regulatory role in gene downregulation, epigenetic editing with histone deacetylation has been sparsely studied, especially in the context of cancer.. In this current study, we have reconstructed a dCas9-HDAC8-EGFP fusion to perform histone deacetylation on the promoter of the ESR1, TERT and CDKN1C genes for the first time in breast cancer cell lines MCF-7 and MDA-MB-231 as well as in HEK293T cells. Membrane:Article Title: A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms. Article Snippet: The membranes were then blocked with 1% Article Title: Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways Article Snippet: Membranes were blocked with 5% non-fat dry milk solution (catalog number 9999) (Cell Signaling Technology, Danvers, MA) at room temperature for 1 h and reacted with the corresponding protein antibodies at 4°C overnight: myeloid differentiation primary response gene 88 (MyD88) (HFL-296, polyclonal; catalog number sc-11356), nuclear factor kappa B (NF-κB) p50 (H-119, polyclonal; catalog number sc-7178), NFκB p65 (F-6, monoclonal; catalog number sc-8008), Caspase-1 (14F468, monoclonal; catalog number sc-56036), GAPDH (FL-335, polyclonal; catalog number sc-25778) (Santa Cruz, Dallas, TX). Article Title: Knockdown of DLGAP5 suppresses cell proliferation, induces G 2 /M phase arrest and apoptosis in ovarian cancer Article Snippet: After conventional blocking with 5% skimmed non-fat dry milk (Cell Signaling Technology, Inc.) for 2 h at room temperature, the membranes were incubated overnight at 4 ̊ C with primary antibodies against CDK1 (1:1,000; cat. no. ab131450; Abcam), Cyclin B1 (1:1,000; cat. no. 4138; Cell Signaling Technology, Inc.), Bax (1:1,000; cat. no. 2772; Cell Signaling Technology, Inc.), Bcl-2 (1:1,000; cat no. sc-7382; Santa Cruz Biotechnology Inc.) and GAPDH (1:1,000; cat. no. G9545; Sigma-Aldrich; Merck KGaA) at 4 ̊C, followed by incubation with secondary antibody conjugated to horseradish peroxidase (1:5,000; cat. no. sc-2357; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. Article Title: dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation. Article Snippet: Epigenetic editing is thriving as a robust tool for manipulating transcriptional regulation and cell fate.. Despite its regulatory role in gene downregulation, epigenetic editing with histone deacetylation has been sparsely studied, especially in the context of cancer.. In this current study, we have reconstructed a dCas9-HDAC8-EGFP fusion to perform histone deacetylation on the promoter of the ESR1, TERT and CDKN1C genes for the first time in breast cancer cell lines MCF-7 and MDA-MB-231 as well as in HEK293T cells. Incubation:Article Title: A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms. Article Snippet: The membranes were then blocked with 1% Article Title: Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways Article Snippet: Membranes were blocked with 5% non-fat dry milk solution (catalog number 9999) (Cell Signaling Technology, Danvers, MA) at room temperature for 1 h and reacted with the corresponding protein antibodies at 4°C overnight: myeloid differentiation primary response gene 88 (MyD88) (HFL-296, polyclonal; catalog number sc-11356), nuclear factor kappa B (NF-κB) p50 (H-119, polyclonal; catalog number sc-7178), NFκB p65 (F-6, monoclonal; catalog number sc-8008), Caspase-1 (14F468, monoclonal; catalog number sc-56036), GAPDH (FL-335, polyclonal; catalog number sc-25778) (Santa Cruz, Dallas, TX). Article Title: Knockdown of DLGAP5 suppresses cell proliferation, induces G 2 /M phase arrest and apoptosis in ovarian cancer Article Snippet: After conventional blocking with 5% skimmed non-fat dry milk (Cell Signaling Technology, Inc.) for 2 h at room temperature, the membranes were incubated overnight at 4 ̊ C with primary antibodies against CDK1 (1:1,000; cat. no. ab131450; Abcam), Cyclin B1 (1:1,000; cat. no. 4138; Cell Signaling Technology, Inc.), Bax (1:1,000; cat. no. 2772; Cell Signaling Technology, Inc.), Bcl-2 (1:1,000; cat no. sc-7382; Santa Cruz Biotechnology Inc.) and GAPDH (1:1,000; cat. no. G9545; Sigma-Aldrich; Merck KGaA) at 4 ̊C, followed by incubation with secondary antibody conjugated to horseradish peroxidase (1:5,000; cat. no. sc-2357; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. Article Title: dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation. Article Snippet: Epigenetic editing is thriving as a robust tool for manipulating transcriptional regulation and cell fate.. Despite its regulatory role in gene downregulation, epigenetic editing with histone deacetylation has been sparsely studied, especially in the context of cancer.. In this current study, we have reconstructed a dCas9-HDAC8-EGFP fusion to perform histone deacetylation on the promoter of the ESR1, TERT and CDKN1C genes for the first time in breast cancer cell lines MCF-7 and MDA-MB-231 as well as in HEK293T cells. |